To study efficacy between Bharangyadi ghrita and Kantakari Ghrita in treatment of Vataja Kasa (Dry cough)
- Conditions
- Health Condition 1: J40- Bronchitis, not specified as acuteor chronicHealth Condition 2: J00-J99- Diseases of the respiratory system
- Registration Number
- CTRI/2022/11/047588
- Lead Sponsor
- PDEAs College of Ayurveda and Research Centre Nigdi Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients presenting with the classical signs and symptoms of Vataj Kasa- Shushka
kasa, Hritshool, Parshvashool, Swarbhed, Kshinabala will be taken for study.
2.Patients with age group between 20-60 years.
3.Patients irrespective of gender, sex, cast, income group and occupation.
1. Patients with known case of Tuberculosis, Chronic Obstructive Pulmonary Diseases
(COPD) like emphysema, bronchitis, bronchiectasis.
2. Patients with age group more than 60 years,
3. Covid 19 positive patients.
4. Patients having uncontrolled Diabetes mellitus (HbA1c more than 8) and
Hypertension (Blood pressure more than 160/110).
5. Immunocompromised patients as AIDS , Cancer etc.
6. Patients with moderate and severe dyspnoea.
7. Patients having SpO2 level below 95%.
8. Patients with hemoptysis.
9. Pregnant ladies and lactating mothers will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the efficacy of Bharangyadi Ghrita 10 ml two times a day after meal with lukewarm water and Kantakari Ghrita 10 ml two times a day after meal with lukewarm water in Vataj kasa for 14 days. <br/ ><br>2. To give maximum symptomatic relief to patients after 14 days of treatment <br/ ><br>3. Relief from symptoms of vataja kasa like shushka kasa, swarbhed, parshvashool, shirshoola after 14 days of treatment.Timepoint: 14 days study with two follow ups on 7th and 14th day
- Secondary Outcome Measures
Name Time Method to study the adverse drug effects if anyTimepoint: 14 days study with two follow ups on 7th and 14th day